Home Nucleus Medical Devices U.S. Uterine Cancer Diagnostics Market to 2032

U.S. Uterine Cancer Diagnostics Market to 2032

Overview

The U.S. Uterine Cancer Diagnostics Market is expected to reach a 6.44 USD Billion by 2032 and is projected to grow at a CAGR of 17.33% from 2025 to 2032.

Revenue, 2024 (USD Billion)
2.63
Forecast, 2032 (USD Billion)
6.44
CAGR, 2024 - 2032
17.33%
Report Coverage
U.S.

U.S. Uterine Cancer Diagnostics Market 2018-2032 USD Billion

U.S. Uterine Cancer Diagnostics Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 2.63 USD Billion
  • Projected Market Size (2032): 6.44 USD Billion
  • CAGR (2025-2032): 17.33%

Key Findings of U.S. Uterine Cancer Diagnostics Market

  • The U.S. Uterine Cancer Diagnostics Market was valued at 2.63 USD Billion in 2024.
  • The U.S. Uterine Cancer Diagnostics Market is likely to grow at a CAGR of 17.33% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Endometrial Cancer in Type Segment accounted for the largest share of the market with a revenue of 10.55 USD Billion
  • The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 21.28% during the forecast period from 2024 to 2032.

U.S. Uterine Cancer Diagnostics Market Scope

U.S. Uterine Cancer Diagnostics Market Segmentation & Scope
Type
  • Uterine Sarcoma
  • Endometrial Cancer
Age Group
  • <30 Years
  • 31-40 Years
  • 41-50 Years
  • 51-60 Years
  • >60 Years
Diagnostic
  • Procedure Based
  • Instrument-Based
Distribution Channel
  • Others
  • Third Party Distributors
  • Direct Tender
End User
  • Others
  • Specialized Clinics
  • Ambulatory Surgical Centers
  • Cancer Research Centers
  • Diagnostic Centers
  • Hospitals

U.S. Uterine Cancer Diagnostics Market Data Coverage Insights

Study Period 2024-2032
Base Year 2021
Unit Revenue in USD Billion
Market Value in 2024 2.63 USD Billion
Market Value in 2032 6.44 USD Billion
CAGR (2025-2032) 17.33%
Historic Data 2016-2023
Market Segments Covered Type,Age Group,Diagnostic,Distribution Channel,End User

Regional Insights:

  • Leading Market (2024-2032): U.S., leading in terms of revenue 2.63 USD Billion in 2024
    • Key Country: U.S., leading in terms of revenue with value of 2,625.60 USD Million in 2024.

Segments and Scope

  • U.S. Uterine Cancer Diagnostics Market to 2032, By Type
    • Endometrial Cancer is the largest segment in U.S. Uterine Cancer Diagnostics Market to 2032 with a revenue of 10.55 USD Billion in the year 2024.
    • Endometrial Cancer is the Fastest growing segment in U.S. Uterine Cancer Diagnostics Market to 2032 with a Growth rate of 17.35 % in forecast period 2025-2032.
  • U.S. Uterine Cancer Diagnostics Market to 2032, By Age Group
    • >60 Years is the largest segment in U.S. Uterine Cancer Diagnostics Market to 2032 with a revenue of 1.21 USD Billion in the year 2024.
    • >60 Years is the Fastest growing segment in U.S. Uterine Cancer Diagnostics Market to 2032 with a Growth rate of 19.27 % in forecast period 2025-2032.
  • U.S. Uterine Cancer Diagnostics Market to 2032, By Diagnostic
    • Instrument-Based is the largest segment in U.S. Uterine Cancer Diagnostics Market to 2032 with a revenue of 1.48 USD Billion in the year 2024.
    • Instrument-Based is the Fastest growing segment in U.S. Uterine Cancer Diagnostics Market to 2032 with a Growth rate of 18.11 % in forecast period 2025-2032.
  • U.S. Uterine Cancer Diagnostics Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in U.S. Uterine Cancer Diagnostics Market to 2032 with a revenue of 1.32 USD Billion in the year 2024.
    • Direct Tender is the Fastest growing segment in U.S. Uterine Cancer Diagnostics Market to 2032 with a Growth rate of 19.42 % in forecast period 2025-2032.
  • U.S. Uterine Cancer Diagnostics Market to 2032, By End User
    • Hospitals is the largest segment in U.S. Uterine Cancer Diagnostics Market to 2032 with a revenue of 968.27 USD Billion in the year 2024.
    • Hospitals is the Fastest growing segment in U.S. Uterine Cancer Diagnostics Market to 2032 with a Growth rate of 21.28 % in forecast period 2025-2032.

U.S. Uterine Cancer Diagnostics Market Company Share Analysis

 
Company Name Company Share Analysis
Medtronic
Koninklijke Philips N.V.
CANON MEDICAL SYSTEMS CORPORATION
General Electric
F. Hoffmann-La Roche Ltd.
U.S. Uterine Cancer Diagnostics Market Company Share Analysis

U.S. Uterine Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Uterine Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Uterine Cancer Diagnostics Market Company Profiling

U.S. Uterine Cancer Diagnostics Market Company Profiling

Industry Related Reports

South America Hospital Furniture Market
Middle East & Africa Hospital Furniture Market
North America Hospital Furniture Market
Europe Hospital Furniture Market
Asia-Pacific Hospital Furniture Market
Argentina Hospital Furniture Market
Australia Hospital Furniture Market
Belgium Hospital Furniture Market
Brazil Hospital Furniture Market
Canada Hospital Furniture Market
Frequently Asked Questions
The U.S. Uterine Cancer Diagnostics Market is segmented based on Segmentation Type,Age Group,Diagnostic,Distribution Channel,End User.
U.S. Uterine Cancer Diagnostics Market was valued at USD 2.63(Revenue in USD Billion) in 2021.
U.S. Uterine Cancer Diagnostics Market is projected to grow at a CAGR of 17.33% during the forecast period of 2024 to 2032.
The Endometrial Cancer segment is expected to dominate the U.S. Uterine Cancer Diagnostics Market, holding a largest market share of 10.55 USD Billion in 2024

U.S. Uterine Cancer Diagnostics Market Scope

U.S. Uterine Cancer Diagnostics Market Segmentation & Scope
Type
  • Uterine Sarcoma
  • Endometrial Cancer
Age Group
  • <30 Years
  • 31-40 Years
  • 41-50 Years
  • 51-60 Years
  • >60 Years
Diagnostic
  • Procedure Based
  • Instrument-Based
Distribution Channel
  • Others
  • Third Party Distributors
  • Direct Tender
End User
  • Others
  • Specialized Clinics
  • Ambulatory Surgical Centers
  • Cancer Research Centers
  • Diagnostic Centers
  • Hospitals
Frequently Asked Questions
The U.S. Uterine Cancer Diagnostics Market is segmented based on Segmentation Type,Age Group,Diagnostic,Distribution Channel,End User.
U.S. Uterine Cancer Diagnostics Market was valued at USD 2.63(Revenue in USD Billion) in 2021.
U.S. Uterine Cancer Diagnostics Market is projected to grow at a CAGR of 17.33% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Uterine Cancer Diagnostics Market for final year is USD 6.44 (USD Billion).

U.S. Uterine Cancer Diagnostics Market Company Profiling

U.S. Uterine Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The U.S. Uterine Cancer Diagnostics Market is segmented based on Segmentation Type,Age Group,Diagnostic,Distribution Channel,End User.
U.S. Uterine Cancer Diagnostics Market was valued at USD 2.63(Revenue in USD Billion) in 2021.
U.S. Uterine Cancer Diagnostics Market is projected to grow at a CAGR of 17.33% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Uterine Cancer Diagnostics Market for final year is USD 6.44 (USD Billion).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES